Bluebird Bio’s gene therapy for blood disorders yields some impressive results ― but also raises questions – STAT
STAT |
Bluebird Bio's gene therapy for blood disorders yields some impressive results ― but also raises questions
STAT he field of gene therapy is making significant strides towards the day when a one-time treatment ― inserting a healthy gene into patients ― could cure a host of inherited, often fatal diseases. But it's been a rocky road 1. And new clinical data … Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at … bluebird bio (BLUE) Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product … |
